Does quantitative contrast-enhanced CMR measuring LGE improve the assessment of SCD event risk in patients with hypertrophic cardiomyopathy?
Extensive LGE on CMR helps stratify sudden cardiac death risk in HCM patients, especially those otherwise considered low risk.
Extensive LGE measured by quantitative contrast enhanced CMR provides additional information for assessing SCD event risk among HCM patients, particularly patients otherwise judged to be at low risk.
Chan et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: